LifeWorks Inc. to be acquired by TELUS creating a global leader in employer-focused healthcare

Highlights The C$2.9 billion transaction advances both LifeWorks and TELUS Health strategic plans to create the unparalleled leader in employee wellness The transaction has received the unanimous approval of LifeWorks’ Board of Directors and is subject to approval by LifeWorks shareholders LifeWorks shareholders will have option to receive C$33.00 per share in cash, TELUS shares … [Read more…]

Global Wrist Replacement Market to 2030 – Featuring KLS Martin LP, Integra Lifesciences Holdings and Stryker Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wrist Replacement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Wrist Replacement Devices market for the year 2020 and beyond. About 75% of the … [Read more…]

New Custom made by ReSound rechargeable hearing aids: the most advanced technology in a stylish design 

The new rechargeable Custom made by ReSound hearing aids give all day comfort and streaming with outstanding sound quality, even in the toughest listening environments. Custom made by ReSound will make people think again about hearing aids by offering the most advanced medical-grade technology in a smart, stylish design. BALLERUP, Denmark–(BUSINESS WIRE)–GN Hearing, the global … [Read more…]

U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.

SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced that the U.S. District Court for the District of Delaware has entered a judgment that Kurin does not infringe U.S. Patent No. 9,855,001 in the patent-infringement lawsuit Magnolia brought against Kurin. Magnolia earlier withdrew two other patents from the case, … [Read more…]

China TAVR & TMV Market Insights & Forecast 2022-2026, Featuring Profiles of Medtronic, Edwards Lifesciences, Venus MedTech HangZhou, MicroPort CardioFlow, Medtech Corporation and Peijia Medical – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The Chinese TAVR market is expected to reach US$1,669.14 million in 2026, growing at a CAGR of 55.50%, for the duration spanning 2022-2026. While, the TMV market in China is forecasted to … [Read more…]

Global Medical Battery Suppliers Leadership Quadrant 2022: Focus on GE, Siemens, Kholberg Kravish Roberts, Boston Scientific, Integer Holding, EaglePicher and Saft – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Leadership Quadrant of Medical Battery Suppliers – 2022” report has been added to ResearchAndMarkets.com’s offering. The medical battery manufacture landscape is diverse and continually evolving. Major players in medical battery market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the medical battery market extends beyond … [Read more…]

Global $25 Billion CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insight on clinical and non-clinical factors that are driving the global CFTR Modulators market and its impact on the global pharmaceutical market landscape. The approval of the first CF transmembrane … [Read more…]

Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A/S, Provider of Competent Bioscience products to … [Read more…]

Genentech Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease

– Crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer’s disease – – For more than a decade Genentech has been working in collaboration with Banner Alzheimer’s Institute, the University of Antioquia in Colombia and the National Institute on Aging on this pioneering prevention study … [Read more…]

Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop Novel Antibody-Based Immuno-Oncology Therapies

– Exelixis positioned to expand its biotherapeutics development pipeline through selection of antibody candidates directed to targets identified using BioInvent’s proprietary immuno-oncology (IO) screening platform and antibody library – ALAMEDA, Calif. & LUND, Sweden–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV) today announced that the companies have entered into an … [Read more…]